Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade

Angiology

Volumn 49, Issue 1, 1998, Pages 41-48

  Wysocki, Marian ^a   Andersson, Ove K ^a   Persson, Bengt ^a   Bagge, Ulf ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLOMERULUS FILTRATION; HEART OUTPUT; HEART RATE; HEMODILUTION; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY BLOOD FLOW; MALE; NATRIURESIS; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PLASMA VISCOSITY; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0031975182     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900105     Document Type: Article

References (23)

1. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 62:347-504, 1982.
2. Letcher RL, Chien S, Pickering TG, et al: Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Am J Med 70: 1195-1202, 1981.
3. Tibblin G, Bergentz S-E, Bjure J, et al: Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J 72:165-176, 1966.
4. Wysocki M, Persson B, Aurell M, et al: Haemodynamic and haemorheological effects of hypervolemic haemodilution in men with primary hypertension. J Hypertens 5:185-189, 1987.
5. Andersson OK, Berglund G, Hansson L, et al: Organization and efficacy of an outpatient hypertension clinic. Acta Med Scand 203:391-398, 1978.
6. Wysocki M, Persson B, Bagge U, et al: Flow resistance and its components in hypertensive men treated with the calcium antagonist isradipine. Eur J Clin Pharmacol 43:463-468, 1992.
7. Nilsson NJ: A linearly responding dichromatic cuvette densitometer for dye-dilution curves. Scand J Clin Lab Invest 15 (suppl 69):181-193, 1963.
8. Krusell RL, Jespersen TL, Schmitz A, et al: Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine. Hypertension 10: 577-581, 1987.
9. Wells RE, Denton R: Measurement of viscosity of biological fluids by cone-plate viscometer. J Lab Clin Med 57:646-656, 1961.
10. Chien S: Hemorheology in disease: Pathophysiological significance and therapeutic implications. Clin Hemorheol 1:419-442, 1981.
11. Lund-Johansen P: Hemodynamics in early essential hypertension. Acta Med Scand 482(suppl):1-101, 1961.
12. Safar ME, London GM, Levenson JA, et al: Rapid dextran infusion in essential hypertension. Hypertension 1:615-623, 1979.
13. Messmer K, Sunder-Plassmann L, Klövekorn WP, et al: Circulatory significance of hemodilution: Rheological changes and limitations. Adv Microcirc 4:1-77, 1972.
14. Andersson OK, Persson B, Wysocki M, et al: Significant relationship between renin suppression and atrial natriuretic peptide (alpha-hANP) during volume loading in hypertensive men. Acta Med Scand 221:137-142, 1987.
15. Richards AM, Nicholls MG, Ikram H, et al: Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1:545-549, 1985.
16. Melkumyants AM, Balashov SA, Khayutin VM: Endothelium dependent control of arterial diameter by blood viscosity. Cardiovasc Res 23:741-747, 1989.
17. Melkumyants AM, Balashov SA: Effect of blood viscosity on arterial flow induced dilator response. Cardiovasc Res 24:165-168, 1990.
18. Otsuka A, Ogihara T, Kohara K, et al: Vasoconstriction and hypersensitivity to vasoactive substances after acute volume expansion in dogs. Hypertension 12:59-66, 1988.
19. Levenson J, Flaud P, Del Pino M, et al: Blood viscosity as a chronic contributing factor of vasodilatation in humans. J Hypertens 8:1049-1055, 1990.
20. Malek AM, Izumo S: Molecular aspects of signal transduction of shear stress in the endothelial cell. J Hypertens 12:989-999, 1994.
21. Koller A, Sun D, Kaley G: Role of shear stress and endothelial prostaglandins in flow-and viscosity-induced dilation of arterioles in vitro. Circ Res 72: 1276-1284, 1993.
22. Joannides R, Haefeli WE, Linder L, et al: Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-1319, 1995.
23. Simchon S, Chen RYZ, Carlin RD, et al: Effects of blood viscosity on plasma renin activity and renal hemodynamics. Am J Physiol 250:F40-F46, 1986.